Large genomic rearrangements (LGR), for example exon level deletions of the BRCA1/2 genes, may escape detection on somatic (tumor) testing by NGS. If FH is positive or the patient is otherwise suspected of inherited cancer, germline genetic testing by a peripheral blood sample should be considered. Here, BRCA1 is linked to neoplasm.